Fulltext

Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion

Babiak, Alexander ; Schumm, Anke-Mira ; Wangler, Christoph ; Loukas, Marios ; Wu, Jianbo ; Dombrowski, Saskia ; Matuschek, Christiane ; Kotzerke, Jörg ; Dehio, Christoph ; Waltenberger, Johannes

In: Cardiovascular Research, 2004, vol. 61, no. 4, p. 789-795

Ajouter à la liste personnelle
    Titre
    • Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion
    Auteur
    • Babiak, Alexander. Department of Internal Medicine II, Ulm University Medical Center, Ulm Germany
    • Schumm, Anke-Mira. Department of Internal Medicine II, Ulm University Medical Center, Ulm Germany
    • Wangler, Christoph. Department of Internal Medicine II, Ulm University Medical Center, Ulm Germany
    • Loukas, Marios. Department of Internal Medicine II, Ulm University Medical Center, Ulm Germany
    • Wu, Jianbo. Department of Internal Medicine II, Ulm University Medical Center, Ulm Germany
    • Dombrowski, Saskia. Department of Internal Medicine II, Ulm University Medical Center, Ulm Germany
    • Matuschek, Christiane. Department of Nuclear Medicine, Ulm University Medical Center, Ulm, Germany
    • Kotzerke, Jörg. Department of Nuclear Medicine, Ulm University Medical Center, Ulm, Germany
    • Dehio, Christoph. Biozentrum of the University of Basel, Basel, Switzerland
    • Waltenberger, Johannes. Department of Internal Medicine II, Ulm University Medical Center, Ulm Germany
    Type de document
    • Postprint
    Identifiant OAI-PMH
    • oai:doc.rero.ch:298476
    Summary
    Objective: The process of arteriogenesis is driven by various growth factors including vascular endothelial growth factor (VEGF)-A, which mediates its activity through VEGFR-2 (Flk-1/KDR) on endothelial cells and through VEGFR-1 (Flt-1) on endothelial cells and monocytes. The purpose of this study was to identify which of the VEGF receptors are involved in arteriogenesis in vivo. Methods: Collateral vessel growth was induced by femoral artery ligation in a mouse model of hindlimb ischemia. Following ligation, Balb/c mice were treated with different growth factors (VEGF-A, VEGF-E, PlGF-2, VEGF-E plus PlGF-2 or VEGF-A plus PlGF-2, activating either VEGFR-1, VEGFR-2, or both). After 1 week of treatment, hindlimb perfusion was assessed by perfusion scintigraphy using Tc-99m-MIBI. Results: The strongest improvement of regional perfusion was achieved by simultaneous activation of VEGFR-1 and VEGFR-2, using either VEGF-A or VEGF-A plus PlGF-2, with elevation of relative perfusion in the ischemic limbs from 0.61 to 0.83. The partial restoration in perfusion was associated with morphological changes typical for arteriogenesis. Moreover, specific inhibition of both VEGF-receptors using ZK 202650 resulted in a significant inhibition of arteriogenesis, indicating an active role of the VEGF system in compensatory arteriogenesis. Conclusion: The coordinated activation of both VEGFR-1 and VEGFR-2 represents a more potent arteriogenic stimulus compared to the isolated activation of either one of these two receptors. These data imply that the activation of both monocytes and endothelial cells is necessary to obtain a maximal VEGF-induced activation of arteriogenesis